We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2026
Programme
Innovative and AI treatment planning
15 May 2026 - 19 May 2026
Stockholm, Sweden
ESTRO 2026
Session
Monday
May 18
10:30 - 11:30
A7
Innovative and AI treatment planning
Chair:
Coen Hurkmans
,
The Netherlands
;
Co-Chair:
Maximilian Grohmann
,
Germany
Session Type:
Proffered Papers
Track:
Physics
Journey:
Add to
My Programme
10:30 - 11:30
Can Extended Reality lead to better 3D spatial perception in Radiation Therapy Planning?
Presenter
:
Annette Schwarz
,
Germany
Presentation Number:
-3835
10:30 - 11:30
Direct Generation of VMAT Plan from Dose and Contours Using Deep Learning-based Auto-planning in Pancreatic Cancer
Presenter
:
Zixu Guan
,
Japan
Presentation Number:
-2036
10:30 - 11:30
Towards LLM-based universal automated treatment planning solution for photon radiotherapy: Application in locally advanced rectal cancer VMAT planning
Presenter
:
Jiacheng Liu
,
China
Presentation Number:
-1804
10:30 - 11:30
An Integrated Simulation Platform: pyPenredPython Module and Blender Plugin for thepenRed Monte Carlo Code
Presenter
:
Sandra Oliver Gil
,
Spain
Presentation Number:
-4834
10:30 - 11:30
Deep-learning dose prediction-driven automated radiation therapy planning for same-day single-fraction treatment of solitary metastasis in the lung
Presenter
:
Mathieu Gaudreault
,
Australia
Presentation Number:
-1963
10:30 - 11:30
A Model-Agnostic AI-based Dose Engine for Real-Time Proton Dose Calculation
Presenter
:
Ahmad Neishabouri
,
Germany
Presentation Number:
-3957
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.